Food and Drug Administration

New Eye Implant May Help Impaired Vision

Submitted by Maryglenn Boals on February 15, 2013 - 9:25am

The Food and Drug Administration approved a new eye-implant technology that will work in place of damaged eye cells. The device’s name is the Argus II Retinal Prosthesis System. The new technology may not be able to fully restore lost vision, but the FDA said, “it may allow them to detect light and dark in the environment,” which could aid in the performance of daily tasks. The implant is only available for a select number of patients as of now. More here

Read more »>

shadow

New Eye Implant May Help Impaired Vision

Submitted by Maryglenn Boals on February 15, 2013 - 9:25am

The Food and Drug Administration approved a new eye-implant technology that will work in place of damaged eye cells. The device’s name is the Argus II Retinal Prosthesis System. The new technology may not be able to fully restore lost vision, but the FDA said, “it may allow them to detect light and dark in the environment,” which could aid in the performance of daily tasks. The implant is only available for a select number of patients as of now. More here

Read more »>

shadow

FDA panel recommends approval of drug to prevent HIV infection

Submitted by ONE Community on May 10, 2012 - 9:18pm

For the first time in the 30-year battle against the HIV epidemic, a panel of experts has recommended that the Food and Drug Administration approve a drug to give to healthy people to protect against the infection.

The panel recommended Thursday that the agency approve the drug Truvada for preventing HIV in men who have sex with men, HIV-negative partners of HIV-postive people and “other individuals at risk for acquiring HIV through sexual activity.”

The FDA usually follows the advice of its advisory committees, which are made up of experts from outside the agency, although it does not have to. Its decision is expected by June 15.

shadow